Canada Viscosupplementation Market Size & Outlook
Canada viscosupplementation market, 2018-2030 (US$M)
Related Markets
Canada viscosupplementation market highlights
- The Canada viscosupplementation market generated a revenue of USD 95.5 million in 2023 and is expected to reach USD 153.0 million by 2030.
- The Canada market is expected to grow at a CAGR of 7% from 2024 to 2030.
- In terms of segment, single injection was the largest revenue generating product in 2023.
- Single Injection is the most lucrative product segment registering the fastest growth during the forecast period.
Viscosupplementation market data book summary
| Market revenue in 2023 | USD 95.5 million |
| Market revenue in 2030 | USD 153.0 million |
| Growth rate | 7% (CAGR from 2023 to 2030) |
| Largest segment | Single injection |
| Fastest growing segment | Single Injection |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single Injection, Three Injection, Five Injection |
| Key market players worldwide | DePuy Synthes, Sanofi SA, Smith & Nephew PLC, Anika Therapeutics Inc, Zimmer Biomet Holdings Inc, Ferring, Lifecore Biomedical Inc, LG Chem, Roche Holding AG |
Other key industry trends
- In terms of revenue, Canada accounted for 2.0% of the global viscosupplementation market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. viscosupplementation market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 3,102.2 million by 2030.
Single injection was the largest segment with a revenue share of 43.56% in 2023. Horizon Databook has segmented the Canada viscosupplementation market based on single injection, three injection, five injection covering the revenue growth of each sub-segment from 2018 to 2030.
One of the popular uses of hyaluronic acid in this region is for knee pain management. In 2014, 6.2% of the population was suffering from osteoarthritis, out of which 32% opted for at least one treatment cycle of intra-articular hyaluronic acid product.
Moreover, companies also contribute to the growth by launching new products in this region. In May 2016, Anika Therapeutics, Inc. launched its thirdgeneration viscosupplement CINGAL. The product had received approval from Heath Canada 2015.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viscosupplementation Market Scope
Viscosupplementation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada viscosupplementation market size, by product, 2018-2030 (US$M)
Canada Viscosupplementation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
